ADXS-Advaxis Announces FDA Acceptance of IND for Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO
This is great news and will start triggering more milestone payments and with $4 per share in cash already ADXS is looking good.
(0)
(0)
Advaxis Inc. (ADXS) Stock Research Links
-
-
-
-
-
-
-